Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

BACKGROUND: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the ongoing controversies, HCQ was recommended for ma...

全面介紹

Na minha lista:
書目詳細資料
發表在:Saudi Pharm J
Main Authors: Almazrou, Saja H., Almalki, Ziyad S., Alanazi, Abdullah S., Alqahtani, Abdulhadi M., Alghamd, Saleh M.
格式: Artigo
語言:Inglês
出版: Elsevier 2020
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527306/
https://ncbi.nlm.nih.gov/pubmed/33020690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.09.019
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍